Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
antibodies
Next-Gen Immunotherapy: Trispecific Antibodies Show 260x Potency Over Traditional Treatments
20 mars 2025 10h24 HE
|
Research and Markets
Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Trispecific Antibodies Clinical Trials, Fast Track Status, Technology Platforms & Market Opportunity Outlook 2025" report has been added to ...
Therapeutic Antibodies, Biosimilars & RNA Therapy Sales Report - Top-Selling Biologic Drugs & Market Trends for 2024
19 mars 2025 08h21 HE
|
Research and Markets
Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "2024 Sales of Therapeutic Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and Therapeutic RNA" report has been added to ...
Inhalable Biologics Industry Report 2025: World Market to Nearly Triple in Size by 2030, Reaching $10.06 Billion at a CAGR of 17.6%
18 mars 2025 05h53 HE
|
Research and Markets
Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies, RNAi-Based...
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - Global Forecast to 2030
12 mars 2025 11h50 HE
|
Research and Markets
Dublin, March 12, 2025 (GLOBE NEWSWIRE) -- The "Complement C4 Antibody Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
Immunotoxins Market Size, Share & Trends Analysis Report 2025: Diphtheria Toxin (DT) Dominated with Market Share of 43.91% in 2024 - Forecasts to 2030
10 mars 2025 05h04 HE
|
Research and Markets
Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Immunotoxins Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030"...
PD-1 x VEGF and PD-L1 x VEGF Bispecific Antibodies Business, Pipeline and Competitor Analysis Report 2025: Comprehensive Overview of R&D and Partnering Activities of Pharma and Technology Companies
03 mars 2025 07h44 HE
|
Research and Markets
Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "PD-1 x VEGF and PD-L1 x VEGF Bispecific Antibodies: A Business, Pipeline And Competitor Analysis From An Industry Perspective" report has been added...
$65.5 Bn Cancer Monoclonal Antibodies Market Analysis by Antibody Type, Medication Type, Application, End-User, and Region 2025-2033
24 févr. 2025 11h20 HE
|
Research and Markets
Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Market by Antibody Type, Medication Type, Application, End-User, and Region 2025-2033" report has been added to ...
Digital Biomanufacturing Market Industry Trends and Global Forecasts to 2035: Digital Twins is the Fastest Growing Segment of the Digital Biomanufacturing Market
10 févr. 2025 13h35 HE
|
Research and Markets
Dublin, Feb. 10, 2025 (GLOBE NEWSWIRE) -- The "Digital Biomanufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Technology, Deployment Options, Type of Biologics and Key...
Cancer Monoclonal Antibody (mAB) Collaboration and Licensing Deals Trends and Analysis Report 2024: Access 599 Agreements Signed by the World's Leading Life Science Companies
31 janv. 2025 09h08 HE
|
Research and Markets
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Cancer Monoclonal...
Antibodies Market Expected To Reach USD 865.62 Billion by 2032, Growing at CAGR 13.93% To Forecast 2024-2032
31 janv. 2025 06h39 HE
|
Introspective Market Research
United States, New York, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Introspective Market Research is excited to unveil its latest report, " Antibodies" This in-depth analysis shows that the global Antibodies...